Kenneth C. Cundy - Dec 9, 2022 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Chief Scientific Officer
Signature
/s/ Kenneth C. Cundy
Stock symbol
ANEB
Transactions as of
Dec 9, 2022
Transactions value $
$0
Form type
4
Date filed
12/13/2022, 08:19 PM
Previous filing
Jun 7, 2022
Next filing
Mar 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +35K $0.00 35K Dec 9, 2022 Common Stock 35K $3.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in a series of sixteen (16) equal quarterly installments on the first day of each calendar quarter, commencing with the first day of the calendar quarter first occurring after December 9, 2022.